Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06957782) titled 'The Value of 68Ga-FAPI PET/CT for Evaluating Peritoneal Treatment Response' on May 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Erasmus Medical Center
Condition:
Peritoneal Metastasis
FAPI
Intervention:
Drug: 68Ga-FAPI-46...
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 2025
Target Sample Size: 16
To know more, visit https://clinicaltrials.gov/ct2/show/NCT06957782
Disclaimer: Curated by HT Syndication....